Yeah I can get a 60% EBITDA margin too, but that was in the pcp. When I update the numbers and assumptions it drops a bit to the ~40% mark - and the decline in margin makes some sense as they are saying that they are keeping their COVID testing capability ramped up "just in case" which makes sense, but would elevate the cost base and chew into the margin.
Ann: Half Yearly Report and Accounts, page-7
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.92 |
Change
-0.320(1.17%) |
Mkt cap ! $12.93B | |||
| Open | High | Low | Value | Volume |
| $27.00 | $27.04 | $26.66 | $25.62M | 955.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 865 | $26.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.95 | 1865 | 3 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| SHL (ASX) Chart |